TLDR:
Key Points:
- The Hong Kong University of Science and Technology has identified early predictors of cancer evolution using AI.
- Study shows that SARS-CoV-2 variants are unlikely to affect T cell responses.
The Hong Kong University of Science and Technology has made significant strides in cancer research and COVID-19 studies. In a recent development, researchers have identified early predictors of cancer evolution under therapy using an artificial intelligence program to analyze tumor samples from glioma patients. This breakthrough could lead to more personalized and effective treatment options for cancer patients.
Additionally, a study conducted at HKUST has revealed that most T cell epitopes targeted upon natural infection are seemingly unaffected by current SARS-CoV-2 variants. This finding provides valuable insights into the immune response to COVID-19 and suggests that existing vaccines may still be effective against new variants of the virus.
These research findings showcase the innovative and impactful work being done at the Hong Kong University of Science and Technology, positioning the institution as a leader in the fields of cancer biology and infectious diseases.
